Newsfeeds - Spark Newswire

1 minute read

FDA
News

Health And Human Services Issues Statement On Mpox; Says Does Not Expect That It Needs To Renew The Emergency Declaration When It Ends On January 31, 2023

By Benzinga Newsdesk

Today, 5:45 PM

https://www.hhs.gov/about/news/2022/12/02/statement-from-hhs-secretary-becerra-on-mpox.html

AEMD

1 minute read

Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs

By Vandana Singh

Today, 5:45 PM

Inovio Pharmaceuticals Inc (NASDAQ:INO) has agreed with its collaborator, the Coalition for Epidemic Preparedness Innovations (CEPI), to discontinue the development of…

INO

1 minute read

INOVIO Discontinues Development Of Lassa Fever And MERS Candidates

By Bill Haddad

Today, 5:45 PM

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious diseases, cancer, and diseases associated with HPV, today announced that it has

INO

3 minute read

‘Now Eggs Are RATIONED: Sainsbury’s Sell Out, Wetherspoon Offers Customers Hash Browns, Sausage Or Onion Rings After Eggs Run Out As Lidl Shoppers Are Limited To Three Cartons Each’ – Daily Mail Reporting On Effects Of Avian Flu

By Benzinga Newsdesk

Today, 5:45 PM

Supermarkets are rationing eggs as shoppers reveal empty shelves and Wetherspoon replaces eggs | Daily Mail Online Britons are apparently panic-buying eggs amid fears of supermarket

IBIO

1 minute read

Why Inovio Pharmaceuticals Stock Is Popping Off

By Henry Khederian

Today, 5:45 PM

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher by 9.11% to $2.34 after the company reported third-quarter financi

INO

21 minute read

Earnings

Earnings Scheduled For November 8, 2022

By Benzinga Insights

Today, 5:45 PM

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.

ABCL

1 minute read

Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa

By Vandana Singh

Today, 5:45 PM

Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases between 2013 and 2017, scientists have found that monkeypox transmission in a remote part of the Democratic Republic of the Congo is much higher than previously thought.

AEMD

3 minute read

‘Scientists Warn Dangerous Monkeypox Variant Circulating In Central Africa Could Fuel New Outbreaks’ – Forbes

By Benzinga Newsdesk

Today, 5:45 PM

Scientists Warn Dangerous Monkeypox Variant Circulating In Central Africa Could Fuel New Outbreaks (forbes.com) A dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa and

AEMD

1 minute read

Inovio Pharma Stops Work On INO-4800 As COVID-19 Heterologous Booster

By Vandana Singh

Today, 5:45 PM

Inovio Pharmaceuticals Inc (NASDAQ:INO) discontinued its internally funded efforts to develop INO-4800 as a COVID-19 heterologous booster vaccine. Jacqueline Shea, CEO…

INO

6 minute read

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:45 PM

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

ACOR